Skip to main content
logo
Restart Life Sciences Corp. (CSE:HEAL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0750
0.00 (0.00%)
Sep 18, 2026, 9:22 AM EST

Restart Life Sciences Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.47-----
Revenue Growth
------
Gross Profit
0.19-----0.01
Operating Income
-1.75-1.3-0.63-1.21-1.85-2.8
Net Income
-1.71-1.390.22-1.22-2.47-2.68
Earnings Per Share
-0.04-0.040.01-0.08-0.18-0.24
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.761.650.170.010.270.22
Total Debt
0.350.250.08---
Net Cash (Debt)
0.411.410.090.010.270.22
Net Cash Growth
57.79%1535.88%963.58%-96.97%21.85%-89.78%
Net Cash Per Share
0.010.040.010.000.020.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.98-0.72-0.07-0.28-2.41-1.95
Capital Expenditures
------
Free Cash Flow
-0.98-0.72-0.07-0.28-2.41-1.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
41.36%-----
Operating Margin
-376.10%-----
Profit Margin
-367.42%-----
FCF Margin
-210.61%-----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--4.81---
PS Ratio
10.07-----